Abstract Details
Pria Anand, MD
(Boston University School of Medicine)
PRESENTER |
Dr. Anand has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
Guelngar Carlos Othon, Jr., MD (National Ignace Deen Hospital, University of Conakry) | Guelngar Carlos Othon has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Andre Vogel (Massachusetts General Hospital) | No disclosure on file |
No disclosure on file | |
Farrah J. Mateen, MD, PhD, FAAN (Northwestern University Department of Neurology) | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |